miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 5, 2025

CoinEx Research November 2025 Report: Painvember's Brutal Reality Check

View original at globenewswire.com
CoinEx Research November 2025 Report: Painvember's Brutal Reality Check HONG KONG, Dec. 05, 2025 (GLOBE NEWSWIRE) -- CoinEx Research’s November 2025 Report: Painvember is a brutal reality check after Uptober’s euphoric highs…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • ZEC's current cycle may not yet be over as it is driven by fundamentals and spot demand

    80% confidence

  • As crypto becomes increasingly institutionalized, macroeconomic factors will play an outsized role in dictating price action

    80% confidence

  • Long-tail Polymarket front-ends are critical to overall censorship resistance and global market penetration

    80% confidence

  • The monopolistic structure of AI infrastructure might be loosening

    80% confidence

  • Bitcoin must defend the critical $80,000-$82,000 support zone to avert a deeper bear phase

    80% confidence

  • Betmoar's volume dominance highlights an 'extreme head effect' driven by superior UX or specific incentives

    80% confidence

  • Bear case: if stablecoin flows shift to significant outflows, could signal bear market lasting at least 6 months similar to April 2022

    80% confidence

  • Bull case: if stablecoin inflows maintain slight growth, current adjustment could end within a quarter similar to May 2024

    80% confidence

  • Next period's stablecoin data is extremely critical and could determine if crypto enters short-term correction or 6+ month bear cycle

    80% confidence

  • November 2025 (Painvember) is a brutal reality check after October's euphoric highs

    80% confidence

  • kimi-k2-thinking marks an intensification of global open-source AI model competition and provides decentralized AI community with new low-cost, high-efficiency model option

    80% confidence

  • BTC is highly likely to retest the $80k zone, and a break below could lead to decline toward $73k

    80% confidence

  • Prediction market has successfully transitioned from 'event-driven' model to phase of 'normalized high liquidity'

    80% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
CoinEx Research November 2025 Report: Painvember's Brutal Reality Check — Source | Via News | es.VIA.NEWS